Loading insider details...
Beta
Latest Form 4 (Aug 19, 2026): Grant/Award of 1,728 AKTX shares, $13.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,728 | $13.0K |
| Aug 5, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,130 | $13.0K |
| Jun 26, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,248 | $12.5K |
| Jan 9, 2026 | BIOVIE INC. (BIVI) | Grant/Award | 57,500 | n/a |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 24,745 | n/a |
| Nov 4, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 32,000 | $24.0K |
| Oct 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 6,277 | $4.6K |